276 related articles for article (PubMed ID: 22158053)
21. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
22. Impact of patient adherence and test performance on the cost-effectiveness of cervical cancer screening in developing countries: the case of Honduras.
Perkins RB; Langrish SM; Stern LJ; Burgess JF; Simon CJ
Womens Health Issues; 2010; 20(1):35-42. PubMed ID: 19944623
[TBL] [Abstract][Full Text] [Related]
23. Secondary prevention of cervical cancer.
Basu P; Mittal S; Bhadra Vale D; Chami Kharaji Y
Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():73-85. PubMed ID: 28988647
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China.
Mo X; Gai Tobe R; Wang L; Liu X; Wu B; Luo H; Nagata C; Mori R; Nakayama T
BMC Infect Dis; 2017 Jul; 17(1):502. PubMed ID: 28720082
[TBL] [Abstract][Full Text] [Related]
25. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
Jain BB; Adhikary T; Sadhukhan PC; Nandi A
J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
[TBL] [Abstract][Full Text] [Related]
26. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
[TBL] [Abstract][Full Text] [Related]
27. Screening for cervical cancer: which common technique is the most cost-effective choice?
Wiwanitkit V
Asian Pac J Cancer Prev; 2009; 10(3):531-2. PubMed ID: 19640204
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review.
Mezei AK; Armstrong HL; Pedersen HN; Campos NG; Mitchell SM; Sekikubo M; Byamugisha JK; Kim JJ; Bryan S; Ogilvie GS
Int J Cancer; 2017 Aug; 141(3):437-446. PubMed ID: 28297074
[TBL] [Abstract][Full Text] [Related]
29. [New strategies for the prevention and control of cervical cancer in Chile.].
Ferreccio C
Salud Publica Mex; 2018; 60(6):713-721. PubMed ID: 30699276
[TBL] [Abstract][Full Text] [Related]
30. A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines.
Guerrero AM; Genuino AJ; Santillan M; Praditsitthikorn N; Chantarastapornchit V; Teerawattananon Y; Alejandria M; Toral JA
BMC Public Health; 2015 Jul; 15():730. PubMed ID: 26223975
[TBL] [Abstract][Full Text] [Related]
31. Reducing overtreatment associated with overdiagnosis in cervical cancer screening-A model-based benefit-harm analysis for Austria.
Sroczynski G; Esteban E; Widschwendter A; Oberaigner W; Borena W; von Laer D; Hackl M; Endel G; Siebert U
Int J Cancer; 2020 Aug; 147(4):1131-1142. PubMed ID: 31872420
[TBL] [Abstract][Full Text] [Related]
32. Comparative assessment of test characteristics of cervical cancer screening methods for implementation in low-resource settings.
Asgary R; Beideck E; Naderi R
Prev Med; 2022 Jan; 154():106883. PubMed ID: 34785209
[TBL] [Abstract][Full Text] [Related]
33. High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.
Reddy D; Njala J; Stocker P; Schooley A; Flores M; Tseng CH; Pfaff C; Jansen P; Mitsuyasu RT; Hoffman RM
Int J STD AIDS; 2015 May; 26(6):379-87. PubMed ID: 24928579
[TBL] [Abstract][Full Text] [Related]
34. Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India.
Sahasrabuddhe VV; Bhosale RA; Kavatkar AN; Nagwanshi CA; Joshi SN; Jenkins CA; Shepherd BE; Kelkar RS; Sahay S; Risbud AR; Vermund SH; Mehendale SM
Int J Cancer; 2012 Jan; 130(1):234-40. PubMed ID: 21387289
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis.
Kulasingam SL; Rajan R; St Pierre Y; Atwood CV; Myers ER; Franco EL
BMC Med; 2009 Nov; 7():69. PubMed ID: 19900264
[TBL] [Abstract][Full Text] [Related]
36. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
[TBL] [Abstract][Full Text] [Related]
37. [Cervical cancer: particularities in HIV patients].
Grellier N; Quéro L
Bull Cancer; 2014 Nov; 101(11):1040-7. PubMed ID: 25418597
[TBL] [Abstract][Full Text] [Related]
38. Benefits and costs of using HPV testing to screen for cervical cancer.
Mandelblatt JS; Lawrence WF; Womack SM; Jacobson D; Yi B; Hwang YT; Gold K; Barter J; Shah K
JAMA; 2002 May; 287(18):2372-81. PubMed ID: 11988058
[TBL] [Abstract][Full Text] [Related]
39. Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening.
Tay SK; Lin LE; Goh RC
Ann Acad Med Singap; 2017 Jul; 46(7):267-273. PubMed ID: 28821890
[TBL] [Abstract][Full Text] [Related]
40. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
